NEWS. Spring 2023 was an interesting time for Sciety. Our goal is to make scientific breakthroughs in medicine and technology available to people all over the world. This is why we strive to help innovative companies within life science and digital health to grow and reach their full potential. In
INSIGHT. Sweden has a long tradition of research and development in life science, supported by a well-functioning ecosystem that encourages collaboration and innovation and drives development forwards. This also lays the foundation for many of the companies that are started here, providing a great deal flow of investment opportunities
NEWS. Tommi Unkuri was appointed a new member of the board of Sciety AB at the general meeting held on June 13th. With extensive experience in building and developing companies within finance and investing in unlisted life science companies, Unkuri is a valuable addition to the board. Tommi Unkuri
PRESS RELEASE. Sciety, a leading Nordic investment company focusing on innovative life science and health tech companies, along with Sciety Venture Partners, invest EUR 1.5 million in Encare. In the funding round, targeting primarily existing shareholders, Sciety and Sciety Venture Partners made their second investment in Encare, supporting the company’s
INSIGHT. From intelligent material design to artificial intelligence. In the future, diagnosis and treatment will use artificial intelligence. There are already several examples in healthcare where artificial intelligence is providing smarter treatments and better diagnostics, and we have only scratched the surface. The market for artificial intelligence in healthcare
PRESS RELEASE. Sciety and Sciety Venture Partners recently completed an investment of EUR 5.3 million in Capitainer, a Swedish medtech company that has developed a unique platform for self-sampling of blood, facilitating remote healthcare solutions and personalized medicine. The capital will be used for sales & marketing and expanding production
Sciety is a capital partner specialising in life science and healthcare, offering services in capital raising and related areas. Sciety may currently have, may previously have had or may in the future be engaged by companies mentioned in our communications or operating in the sectors described, and may hold ownership interests in such companies. Sciety receives remuneration for its services, including commissions in connection to capital raises. Our communication is intended for informational purposes only and does not constitute personal investment advice. We do not guarantee the accuracy, completeness or timeliness of the information provided. Investment decisions should not be based solely on this communication.